Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001890784-26-000003

Options or other derivatives

  • Chief Accounting Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Anand Bhaskar Chief Accounting Officer 2026-01-08 Grant or award · Stock Option (right to buy) +30,000 30,000 D
Loading xslF345X05/wk-form4_1768251691.xml…